Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are actively carried out around the world. Several vaccines are currently approved for emergency use in the population, while ongoing studies continue to provide information on their safety and eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte, Luisa F., Gálvez, Nicolás M. S., Iturriaga, Carolina, Melo-González, Felipe, Soto, Jorge A., Schultz, Bárbara M., Urzúa, Marcela, González, Liliana A., Vázquez, Yaneisi, Ríos, Mariana, Berríos-Rojas, Roslye V., Rivera-Pérez, Daniela, Moreno-Tapia, Daniela, Pacheco, Gaspar A., Vallejos, Omar P., Hoppe-Elsholz, Guillermo, Navarrete, María S., Rojas, Álvaro, Fasce, Rodrigo A., Fernández, Jorge, Mora, Judith, Ramírez, Eugenio, Zeng, Gang, Meng, Weining, González-Aramundiz, José V., González, Pablo A., Abarca, Katia, Bueno, Susan M., Kalergis, Alexis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511644/
https://www.ncbi.nlm.nih.gov/pubmed/34659237
http://dx.doi.org/10.3389/fimmu.2021.742914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511644/
https://www.ncbi.nlm.nih.gov/pubmed/34659237
http://dx.doi.org/10.3389/fimmu.2021.742914

Ejemplares similares